148
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Intravitreal Fluocinolone 0.19mg Implant in the Management of Chronic Non-Infectious Uveitis: 12-Month Outcomes from a Single Tertiary Centre

, MD, , MD, , MBBS FRCS DO MS, , Prof BSc MBChB DO FRCSEd FRCOphth & , MBChB (Hons), FRCOphth
Pages 1572-1578 | Received 28 Dec 2020, Accepted 20 Apr 2021, Published online: 14 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nitin Kumar Menia, Sashwanthi Mohan & Aniruddha Agarwal. (2023) Intravitreal immunotherapy in non-infectious uveitis: an update. Expert Review of Clinical Pharmacology 16:10, pages 959-976.
Read now

Articles from other publishers (2)

Anne Studsgaard, Kåre Ørts Clemmensen & Mette Slot Nielsen. (2021) Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients. Graefe's Archive for Clinical and Experimental Ophthalmology 260:5, pages 1633-1639.
Crossref
Lucy Joanne Kessler, Grzegorz Łabuz, Gerd U. Auffarth & Ramin Khoramnia. (2022) Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema. Pharmaceutics 14:4, pages 688.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.